Why Partner With TriNet Pharma?

We here at TriNet Pharma truly understand that each of our clients are unique in their needs, their goals and their timelines. As a result, we build each new client team specifically designed to meet those needs and pride ourselves on being able to deliver customized solutions for our clients.

TriNet Pharma provides our clients with a two-fold approach to the development of a new team. First, our Vice President of MSL Operations, Dr. Stacey Benefiel, has over 25 years of Industry experience. This experience includes working as a MSL, as well as overseeing and developing several MSL teams as a Director within organizations such as Procter & Gamble, Acorda and Medtronic. Her experience and expertise helps guide our clients through the process of developing a new team by anticipating decision-making points, deciding on appropriate team size, identifying the most effective team composition characteristics, developing a timeline based upon company targets, etc. We truly value our client relationships as a partnership and we will strive to ensure their success.

Secondly, our recruiting capabilities allow our clients to interview only those candidates that truly meet their specific needs. We will not present candidates that we do not believe would be strong, viable candidates. Our recruiters have extensive relationships across the industry that allow us access to a tremendous number of MSLs. Our database is the most robust in the industry. As a result, our ability to contact these candidates is unsurpassed.

Our over-arching goal is to ensure our clients are provided with a productive team that exceeds their expectations. To-date, 80% of our contract MSL candidates have been internalized by our clients. For those that have not, nearly all of those were due to a failed clinical trial or negative communication from the FDA which resulted in a dissolution of the team. If you would like more information about first-hand client experiences, we are more than happy to provide a list of references.